These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29855382)

  • 21. Drosha inclusions are new components of dipeptide-repeat protein aggregates in FTLD-TDP and ALS C9orf72 expansion cases.
    Porta S; Kwong LK; Trojanowski JQ; Lee VM
    J Neuropathol Exp Neurol; 2015 Apr; 74(4):380-7. PubMed ID: 25756586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycine-alanine dipeptide repeat protein contributes to toxicity in a zebrafish model of C9orf72 associated neurodegeneration.
    Ohki Y; Wenninger-Weinzierl A; Hruscha A; Asakawa K; Kawakami K; Haass C; Edbauer D; Schmid B
    Mol Neurodegener; 2017 Jan; 12(1):6. PubMed ID: 28088213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneous ribonuclear protein A3 (hnRNP A3) is present in dipeptide repeat protein containing inclusions in Frontotemporal Lobar Degeneration and Motor Neurone disease associated with expansions in C9orf72 gene.
    Davidson YS; Flood L; Robinson AC; Nihei Y; Mori K; Rollinson S; Richardson A; Benson BC; Jones M; Snowden JS; Pickering-Brown S; Haass C; Lashley T; Mann DMA
    Acta Neuropathol Commun; 2017 Apr; 5(1):31. PubMed ID: 28431575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis.
    Götzl JK; Mori K; Damme M; Fellerer K; Tahirovic S; Kleinberger G; Janssens J; van der Zee J; Lang CM; Kremmer E; Martin JJ; Engelborghs S; Kretzschmar HA; Arzberger T; Van Broeckhoven C; Haass C; Capell A
    Acta Neuropathol; 2014; 127(6):845-60. PubMed ID: 24619111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: clinicopathologic correlation.
    Bigio EH; Weintraub S; Rademakers R; Baker M; Ahmadian SS; Rademaker A; Weitner BB; Mao Q; Lee KH; Mishra M; Ganti RA; Mesulam MM
    Neuropathology; 2013 Apr; 33(2):122-33. PubMed ID: 22702520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.
    Nicholson AM; Finch NA; Wojtas A; Baker MC; Perkerson RB; Castanedes-Casey M; Rousseau L; Benussi L; Binetti G; Ghidoni R; Hsiung GY; Mackenzie IR; Finger E; Boeve BF; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Rademakers R
    J Neurochem; 2013 Sep; 126(6):781-91. PubMed ID: 23742080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circadian sleep/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases.
    Dedeene L; Van Schoor E; Vandenberghe R; Van Damme P; Poesen K; Thal DR
    Acta Neuropathol Commun; 2019 Dec; 7(1):189. PubMed ID: 31791419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low Serum High-Density Lipoprotein Cholesterol Levels Associate with the C9orf72 Repeat Expansion in Frontotemporal Lobar Degeneration Patients.
    Jääskeläinen O; Solje E; Hall A; Katisko K; Korhonen V; Tiainen M; Kangas AJ; Helisalmi S; Pikkarainen M; Koivisto A; Hartikainen P; Hiltunen M; Ala-Korpela M; Soininen H; Soininen P; Haapasalo A; Remes AM; Herukka SK
    J Alzheimers Dis; 2019; 72(1):127-137. PubMed ID: 31561355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unconventional features of C9ORF72 expanded repeat in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Vatovec S; Kovanda A; Rogelj B
    Neurobiol Aging; 2014 Oct; 35(10):2421.e1-2421.e12. PubMed ID: 24836899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-incidental C9orf72 expansion mutation-related frontotemporal lobar degeneration pathology and sporadic Creutzfeldt-Jakob disease.
    Klotz S; König T; Erdler M; Ulram A; Nguyen A; Ströbel T; Zimprich A; Stögmann E; Regelsberger G; Höftberger R; Budka H; Kovacs GG; Gelpi E
    Eur J Neurol; 2021 Mar; 28(3):1009-1015. PubMed ID: 33131137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene.
    Baborie A; Griffiths TD; Jaros E; Perry R; McKeith IG; Burn DJ; Masuda-Suzukake M; Hasegawa M; Rollinson S; Pickering-Brown S; Robinson AC; Davidson YS; Mann DM
    Neuropathol Appl Neurobiol; 2015 Aug; 41(5):601-12. PubMed ID: 25185840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The FTLD Risk Factor TMEM106B Regulates the Transport of Lysosomes at the Axon Initial Segment of Motoneurons.
    Lüningschrör P; Werner G; Stroobants S; Kakuta S; Dombert B; Sinske D; Wanner R; Lüllmann-Rauch R; Wefers B; Wurst W; D'Hooge R; Uchiyama Y; Sendtner M; Haass C; Saftig P; Knöll B; Capell A; Damme M
    Cell Rep; 2020 Mar; 30(10):3506-3519.e6. PubMed ID: 32160553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion.
    Waite AJ; Bäumer D; East S; Neal J; Morris HR; Ansorge O; Blake DJ
    Neurobiol Aging; 2014 Jul; 35(7):1779.e5-1779.e13. PubMed ID: 24559645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy.
    Mao F; Robinson JL; Unger T; Posavi M; Amado DA; Elman L; Grossman M; Wolk DA; Lee EB; Van Deerlin VM; Porta S; Lee VMY; Trojanowski JQ; Chen-Plotkin AS
    Acta Neuropathol; 2021 Oct; 142(4):629-642. PubMed ID: 34152475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C9ORF72 dipeptide repeat poly-GA inclusions promote intracellular aggregation of phosphorylated TDP-43.
    Nonaka T; Masuda-Suzukake M; Hosokawa M; Shimozawa A; Hirai S; Okado H; Hasegawa M
    Hum Mol Genet; 2018 Aug; 27(15):2658-2670. PubMed ID: 29750243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene-Specific Effects on Brain Volume and Cognition of
    Vandebergh M; Ramos EM; Corriveau-Lecavalier N; Ramanan VK; Kornak J; Mester C; Kolander T; Brushaber DE; Staffaroni AM; Geschwind DH; Wolf AA; Kantarci K; Gendron T; Petrucelli L; Van den Broeck M; Wynants S; Baker M; Borrego-Écija S; Appleby B; Barmada S; Bozoki AC; Clark D; Darby RR; Dickerson BC; Domoto-Reilly K; Fields JA; Galasko D; Ghoshal N; Graff-Radford NR; Grant IM; Honig LS; Hsiung GR; Huey ED; Irwin DJ; Knopman DS; Kwan JY; Léger GC; Litvan I; Masdeu JC; Mendez MF; Onyike CU; Pascual B; Pressman PS; Ritter A; Roberson ED; Snyder A; Sullivan AC; Tartaglia MC; Wint D; Heuer HW; Forsberg LK; Boxer AL; Rosen HJ; Boeve BF; Rademakers R;
    Neurology; 2024 Oct; 103(8):e209832. PubMed ID: 39321401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency.
    Arrant AE; Nicholson AM; Zhou X; Rademakers R; Roberson ED
    Mol Neurodegener; 2018 Jun; 13(1):32. PubMed ID: 29929528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.
    Finch N; Carrasquillo MM; Baker M; Rutherford NJ; Coppola G; Dejesus-Hernandez M; Crook R; Hunter T; Ghidoni R; Benussi L; Crook J; Finger E; Hantanpaa KJ; Karydas AM; Sengdy P; Gonzalez J; Seeley WW; Johnson N; Beach TG; Mesulam M; Forloni G; Kertesz A; Knopman DS; Uitti R; White CL; Caselli R; Lippa C; Bigio EH; Wszolek ZK; Binetti G; Mackenzie IR; Miller BL; Boeve BF; Younkin SG; Dickson DW; Petersen RC; Graff-Radford NR; Geschwind DH; Rademakers R
    Neurology; 2011 Feb; 76(5):467-74. PubMed ID: 21178100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.
    Brettschneider J; Van Deerlin VM; Robinson JL; Kwong L; Lee EB; Ali YO; Safren N; Monteiro MJ; Toledo JB; Elman L; McCluskey L; Irwin DJ; Grossman M; Molina-Porcel L; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2012 Jun; 123(6):825-39. PubMed ID: 22426854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degeneration.
    Reich M; Simon MJ; Polke B; Paris I; Werner G; Schrader C; Spieth L; Davis SS; Robinson S; de Melo GL; Schlaphoff L; Buschmann K; Berghoff S; Logan T; Nuscher B; de Weerd L; Edbauer D; Simons M; Suh JH; Sandmann T; Kariolis MS; DeVos SL; Lewcock JW; Paquet D; Capell A; Di Paolo G; Haass C
    Sci Transl Med; 2024 Jun; 16(750):eadj7308. PubMed ID: 38838131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.